A Review of the Clinical Pharmacokinetics of Polymyxin B

Polymyxin B remains an antibiotic of last resort because of its toxicities. Although newer therapies are becoming available, it is anticipated that resistance to these agents will continue to emerge, and understanding the safest and most efficacious manner to deliver polymyxin B will remain highly i...

Descripción completa

Detalles Bibliográficos
Autores principales: Avedissian, Sean N., Liu, Jiajun, Rhodes, Nathaniel J., Lee, Andrew, Pais, Gwendolyn M., Hauser, Alan R., Scheetz, Marc H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466567/
https://www.ncbi.nlm.nih.gov/pubmed/30909507
http://dx.doi.org/10.3390/antibiotics8010031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466567/
https://www.ncbi.nlm.nih.gov/pubmed/30909507
http://dx.doi.org/10.3390/antibiotics8010031

Ejemplares similares